BiomeBank is a clinical stage biotechnology company, founded in South Australia in 2024. This approval is a landmark for BiomeBank and an important advance for microbiome therapeutics globally. We are thrilled to achieve market authorisation and intend to scale manufacturing of our donor derived microbiome drug product to meet the immediate ... WebBiomeBank is a clinical stage biotechnology company developing a pipeline of microbiome therapies to treat unmet medical need. BiomeBank's mission is to treat and prevent disease by restoring gut microbial ecology. Backed by a world-leading team of translational microbiome experts, BiomeBank's platform uses a unique combination of machine ...
Sarah Haylock-Jacobs - Head of Clinical Development
WebJan 2, 2024 · BiomeBank’s office is located in a hub in the suburbs of Adelaide. Chief medical officer Sam Costello and chief executive Thomas Mitchell wear lanyards emblazoned with depictions of bacteria ... WebJan 31, 2024 · BiomeBank 31 January 2024 Adelaide’s BiomeBank recently made the news when they became first in the world to gain regulatory approval for a donor derived … grant writing calendar
Jo Close on LinkedIn: BiomeBank announces world first regulatory ...
WebNov 14, 2024 · It gives BiomeBank the go ahead for a “microbiome-based therapy product”, or BIOMICTRA for short, to treat C. diff infections that could otherwise be fatal. WebNov 28, 2024 · Australia's Therapeutic Goods Administration (TGA) recently approved BiomeBank’s “microbiome-based therapy product,” or BIOMICTRA. This is the first regulatory approval for a FMT product. WebBiomeBank is a clinical stage biotechnology company with a mission to treat and prevent disease by restoring gut microbial ecology. Introducing BiomeBank (1:40) BiomeBank is on a mission to treat and prevent … grant writing california